|> Highlights of the American College of Rheumatology 2011 Annual Scientific Meeting
> First Lupus Nephritis Diagnosis and Management Guidelines Released
> The Latest Treatment Advances for Lupus
> Update on Biomarkers
> Women with Lupus Can Have a Safe Pregnancy and Healthy Baby
> Vitamin D: Intriguing Data
> Systemic Lupus Erythematosus Registries: Providing Critical Information
> Cognitive Function in Systemic Lupus Erythematosus
> References and Acknowledgments
Vitamin D: Intriguing Data
They’ve been calling vitamin D the miracle vitamin for years, implicating low levels of the so-called “sunshine vitamin” in everything from heart disease to autoimmune conditions like multiple sclerosis and, yes, lupus. What is less clear, however, is if supplementing with vitamin D in people with low blood levels has any effect on lupus disease progression or its symptoms. Although the research is still in its infancy, it is providing some intriguing clues. Here’s what we learned at this year’s meeting:
“These represent very preliminary results,” said lead researcher Benjamin Terrier, MD, of the Internal Medicine Department of the Pitié-Salpétrière Hospital in Paris, France, during a press conference. Given the absence of a control group, he said, he couldn’t even say for sure that the immunologic effects were related to the vitamin D. However, he also called the results “encouraging” because they demonstrated the safety of such high doses of vitamin D in people with lupus.
Next step: Randomized clinical trials
Key point: Supplementing with vitamin D may provide some benefits for people with lupus who have low blood levels of the vitamin, but large, randomized clinical trials are necessary.
More information about lupus and treatment advances can be found by visiting www.lupusresearch.org.
The Alliance for Lupus Research Special Report on the 2011 American College of Rheumatology Meeting was made possible in part by generous support from Genentech.
©2011 Alliance for Lupus Research. All Rights Reserved.
Contents herein may not be reproduced, republished or distributed without the prior written permission of the Alliance for Lupus Research. To request permission to reproduce, republish or distribute any part of this report, contact us at 212-218-2840 or email email@example.com.